Serotonin as a mast cell product by Crabb, Edward Drane
University of Colorado, Boulder
CU Scholar
Series in Biology Ecology & Evolutionary Biology
Spring 4-1-1958
Serotonin as a mast cell product
Edward Drane Crabb
Follow this and additional works at: http://scholar.colorado.edu/sbio
This Article is brought to you for free and open access by Ecology & Evolutionary Biology at CU Scholar. It has been accepted for inclusion in Series in
Biology by an authorized administrator of CU Scholar. For more information, please contact cuscholaradmin@colorado.edu.
Recommended Citation
Crabb, Edward Drane, "Serotonin as a mast cell product" (1958). Series in Biology. 13.
http://scholar.colorado.edu/sbio/13
SEROTONIN AS A MAST CELL PRODUCT
E dward D ra n e  C r a bb
The occurrence of serotonin (43, 334, 493, 536), as well as heparin and histamine 
(42, 473, 476), in mast cells has been established. Although Parratt and West, 
1956, (536) and the investigators cited above show that serotonin occurs in mast 
cells, the significance of the mast cell as a source of serotonin is not clear at this 
time. One of the disturbing factors is that there are strong indications that 5- 
hydroxytryptophan, the immediate percursor of serotonin, occurs in practically 
all tissues of the body (77) where it may be decarboxylated to form serotonin 
within the cells (77, 587). Also, Brodie, 1957, points out that administration of 
5-hydroxytryptophan will be followed by appearance of serotonin in all tissues in 
the body (77).
The results of work with a dog and a mouse transplantable mast cell tumor both 
support and contradict the finding that there is a correlation between the occur­
rence of serotonin and the mast cell population in rat skin (43). The mastocytoma 
of mice contained both serotonin and histamine in large amounts; in the masto­
cytoma of dogs the serotonin level was not affected, but the histamine concentra­
tion was increased (536). However, the activity of serotonin, as indicated by strips 
of rat colon in extracts, has been found to parallel the mast cell population in the 
skin and in concentrations of peritoneal fluid from rats (43). Contrarily, it has 
been reported that Erspamer, 1954, was unable to correlate the distribution of 
serotonin with mast cell content in rat tissues (474). The ratio of serotonin to his­
tamine in mast cells from peritoneal fluid and skin of rats ranged between 1:16 
and 1:26 when estimated by two different methods (493). Nevertheless, it is un­
certain whether the available results of investigations to date warrant the general 
acceptance of the statement that there is a likelihood that "5-hydroxytryptamine 
is the edema-producing agent released by substances which damage mast cells" 
(493) in rats.
G e n er a l  C onsiderations
Rapport and co-workers (461) reported the isolation of a crystalline, vasocon­
strictor substance from beef serum and proposed the name "serotonin" for it in 
1948, to indicate its source and physiologic functions, and Rapport, 1949, found 
that serotonin is a complex of equimolecular parts of sulfuric acid, creatinine, and 
5-hydroxyindole base (422). Although use of this term has since become wide­
spread, results of the biological methods by which serotonin is often identified in 
animal tissues are sometimes bewildering to the reviewer. Selye (520), after re­
viewing the divergent literature, apparently considers "beta thrombovasine",
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"vasoconstrictine" and "vasotonine" of various authors as being probably identi­
cal with Freund's, 1920, 1921, clot fluid, "Spatgift". One significant point about 
the concept of "serotonin" and the other 4 terms is that each term indicates a 
substance having a vasoconstricting action, which is the characteristic vascular 
effect generally attributed to serotonin by most investigators. Some investigators, 
however, not only relate serotonin to "Spatgift" in a general way, as a vasocon­
strictor, but point out that "serotonin is a clot retraction principle" and is possibly 
the only dialyzable factor in platelets which is capable of causing retraction of the 
clot (187).
The generally accepted definition and synonomy of the hormone (633), sero­
tonin, brings out the following points: "Serotonin. 5-Hydroxytrptamine. 5-Hy- 
droxy-3-(B-aminoethyl) indole. Vasoconstrictor found in sera of mammals . . ." 
(389). Serotonin is also called thrombocytin (588), enteramine (171, 207), when 
obtained from invertebrates (171) or from the gastrointestinal enterochromaffin 
cells from the mucosa of vertebrates (171).
There are several kinds or preparations and sources of serotonin, such as bufo- 
tenin (dimethyl serotonin obtained from cohoba (2)); trimethyl serotonin, a 
quartenary, positively charged derivative of serotonin which was identified in 
cohoba seeds by Horning (2); N-methylserotonin, which by a second methylation 
becomes N-dimethylserotonin or bufotenin (180); a water-soluble 2,5-dimethyl- 
serotonin (525), serotonin creatinine sulfate (122, 360), 5-hydroxytryptamine 
picrate (171); enteramine, obtained from organs of certain invertebrates, especially 
the common octopus, Octopus vulgaris, and skin of the disc-tongued toad, Dis- 
coglossus pictus (171), and as an unmethylated precursor of Bufo marinus venom 
(558) and from argentaffme or enterochromaffin (whence the name "enteramine") 
cells from the gastro-intestine of vertebrates (171) and other sources. It has been 
suggested that many (171), possibly most, of the preparations of serotonin have 
similar action. However, enteramine obtained from the posterior salivary glands 
of the common octopus is not desirable for certain types of experimental work. 
In addition to serotonin it contains octopamine (1-norsynephrine) and tyramine, 
both of which are markedly diuretic in action since they produce systemic hyper­
tension and constrict the efferent glomerular arterioles in the kidney (173), while 
serotonin normally constricts the afferent glomerular arterioles (170) and is, 
therefore, antidiuretic in its action (173).
R e l e a s e  of S erotonin
It is highly probable that serotonin may be found to have important relations 
to enzymic activities, for it has recently been reported to have antioxidant effects, 
especially in inhibiting the formation of lipid peroxidase in tissues (45).
The release of serotonin parallels that of histamine in certain ways. Both sero­
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tonin and histamine are released from mast ceils by histamine-releasing agents 
(493), both may be released from structures or cells within or associated with 
which mast cells are either very sparse or totally absent, and both serotonin and 
histamine may be released by the same or by various non-related agents. It has 
been suggested (474) and shown (493) that histamine-releasing agents, especially 
those that release histamine from mast cells, such as ovomucoid, compound 48/80 
dextran, and extract of testis, disrupt the mast cells and also release both seroto­
nin and histamine from these cells in rats. However, Brodie and co-workers, 1955, 
showed that reserpine readily releases serotonin deposited in the brain of mice 
and rabbits (122), and others of the same group (248, 333, 529) have verified and 
extended these findings.
It is apparent that the serotonin content of central nervous tissue is not related 
to its mast cell content since mast cells do not occur within the central nervous 
system of any species (474), and the histamine content of central nervous tissue 
is very low, "not exceeding a few ug/g  tissue" (608), with only 0.05 ng/g in the 
spinal cord (615), while the serotonin content is relatively high in the brain of 
normal rabbits (0.55 ug/g) (77), 200 to 250 uug/g  wet weight in the brain of rats 
(611), and was increased enormously in dogs, at least "ten times the normal level", 
by intravenous injection of its precursor, 5-hydroxytryptophan (60 mg/k) (591), 
and up to 20 fold in rabbits (587) and in the brain and periphery of human patients 
(633).
Work with mast cell tumors in mice and dogs and with carcinoids (tumors de­
rived from chromaffin cells of the gastrointestinal mucosa) presents sources of 
increased serotonin and, usually, of histamine. Transplantation of an ascitic form 
of solid mast cell tumor increased the total serotonin content about 14 times and 
the total histamine content about 22 times in mice; a transplantable mast cell 
tumor in dogs developed a marked increase in histamine but the serotonin content 
was not affected (536). It has also been pointed out that although chromaffinomas 
of the intestine "contain large amounts of serotonin" a few of these tumors may be 
found having only small amounts of histamine (536).
Although one can hardly suppress his curiosity, it is too early in the recognized 
life of serotonin as a potent edema-producing agent (493) to determine which of 
the various agents known to release serotonin also release histamine. It has, how­
ever, been stated that compound 48/80, dextran, ovomucoid, and extract of testes 
disrupt mast cells and release both serotonin and histamine from these cells, and 
that serotonin subcutaneously injected into rats' feet caused marked edema with­
out damaging the mast cells (493).
Reserpine administered as a single large dose (5 mg/kg) to laboratory animals 
caused nearly complete release of serotonin from the brain, blood platelets, and 
intestinal tract (248). However, serotonin in the intestine is more resistant to
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release by reserpine than that in the blood platelets or brain. Reserpine (0.015 
mg/k) administered daily for 3 months caused a progressive decline of serotonin 
in the platelets and, to a less degree, in the brain, but failed to cause any significant 
change in the level of serotonin in the intestine of rabbits (248). Administration 
of 1.0 mg doses of reserpine daily for 10 days to 3 hypertensive people had a 
cumulative effect as shown by its causing a 95 per cent reduction in serotonin 
content of blood platelets. A progressive decline in serotonin content of platelets 
was observed in rabbits receiving 0.015 mg/kg daily, but serotonin levels in the 
brain were reduced to a lesser degree, while the serotonin level of the intestine 
was not significantly changed (248). It has also been pointed out that although 
reserpine readily releases serotonin from blood platelets of rabbits in vivo and in 
vitro, "neither histamine nor protein is liberated from platelets"; consequently, 
"no general change in permeability is involved" (529). This observation is partly 
supported by Humphrey and Jaques, 1956, who found that antigen-antibody 
combination and possibly several other agents release histamine and, presumably, 
serotonin from platelets without altering the form or structure of the platelets in 
any way detectable under a phase-contrast microscope (595).
Zucker and Borelli (644) found that serotonin preformed in blood platelets can 
be completely liberated "without disintegration, agglutination or cohesion" of 
the washed platelets as related to the process of blood clotting produced by a 
variety of factors. Bigelow (52) also reports the liberation of platelet serotonin 
without visible injury to the platelets. Other investigators report that intraperi­
toneal injection of reserpine phosphate caused release of platelet serotonin without 
disruption of the platelets (530). Plasma containing calcium appears to be essential 
for the release of either serotonin or histamine from blood platelets. Humphrey, 
1956, using washed platelets from the buffy coat of centrifuged rabbit blood 
concentrated in "a suitable suspending medium without plasma", found that 
addition of the proteolytic enzyme trypsin released histamine from the platelets, 
but that no histamine was released when a histamine liberator, thalassin or com­
pound 48/80, was added to the suspension. These results indicated to him that 
the presence of plasma is essential for release of histamine from rabbit platelets 
by histamine liberators (595). Later, employing a more decisive approach, Hum­
phrey and Jaques, 1956, showed that not only plasma but also calcium is necessary 
for the release of either serotonin or histamine from rabbit platelets. When the 
washed platelets, prepared as in the previous experiments, were mixed with 
antibody (which had been purified by salt fractionation) followed by antigen, 
precipitate was formed in abundance, but neither serotonin nor histamine was 
released. When plasma and calcium were incorporated in the suspension of plate­
lets the addition of antigen and antibody released both serotonin and histamine 
(595).
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The use of compound 48/80 to liberate histamine from platelets invites discus­
sion, for compound 48/80 is considered by certain investigators, if not generally, 
as being a "fairly specific histamine liberator" for mast cells (474) and is held by 
Perry, 1955, as being "completely inactive" in releasing histamine from platelets 
(595). Perry, 1956, also states that the antigen-antibody complex is known to 
release histamine from platelets regularly and he goes even further by suggesting 
that investigators consider compound 48/80 specific for release of histamine from 
mast cells (595).
The amount of serotonin in normal blood has been determined for man and 
certain mammals and is expressed in terms of gammas of serotonin in one milliliter 
of whole blood: For the rabbit, 4.00 v/ ml; beef, 1.7; dog, 0.25; rat, 0.20; guinea 
pig, 0.15; and man 0.10 (590).
I n h ibition  of Serotonin
There is a surprisingly large number and range of agents which may destroy 
serotonin or antagonize certain of its actions. The mention of a few of these agents 
and their mode of action may reflect some light on the relationship of serotonin 
to capillary permeability changes. However, few of these agents appear to be 
specific for serotonin, as has been repeatedly pointed out (483), and others exhibit 
preferential antagonism of certain activities of serotonin. A good example of this 
relationship is given by Woolley (632) who emphatically points out that many 
antagonists of the spastogenic effects of serotonin on smooth muscle do not have 
any mental effects. Cerletti (94) also cautions that many antagonists of the spasto­
genic effect of serotonin on excised smooth muscle are practically ineffective in 
living animals. Welsh (613) suggests that serotonin is essential in certain inverte­
brates to mediate nerve action and that nerve action is abolished by those agents 
which block the action of serotonin.
Free serotonin is rapidly degradated by one or more amine oxidases. This rapid 
utilization may help to explain the absence of serotonin in many structures, 
especially in those structures in which its precursor, 5-hydroxytryptophan or 
tryptophan is present in the absence of serotonin. Other investigators (360) 
suggest that serotonin intravenously injected into human subjects is trapped, 
transported, and released by blood platelets and that it may be absorbed and later 
slowly released by tissues.
The fact that 5 normal dogs after receiving serotonin creatinine sulfate (10.0 
ug/kg/min) by intravenous infusion for 3 hours showed no effects of the serotonin, 
such as hypotension and bradycardia, supports the tenet plasma serotonin is 
rapidly metabolized, probably by monoamine oxidase, as in the brain (77) or in 
the oxidative deamination of parenterally administered serotonin, to form an 
intermediate of 5-hydroxyindoleacetic acid (591). Earlier works merely indicate 
that serotonin is rapidly inactivated by amine oxidase (193).
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Alteration in the functional activity of serotonin in the brain may result in 
psychiatric and behavioral changes in laboratory animals and man (632). Likewise, 
Gaddum, 1953, has shown that an excess of serotonin will specifically inhibit its 
own action. For example, an excess of serotonin produces insensitivity of the 
uterus of rats to smaller although ordinarily physiologically active amounts of 
this hormone (632).
A ntihistamtnic D rugs
Several antihistamines, including benadryl, phenergan, and thenfadil, reduced 
the pressor but not the depressor action of serotonin in dogs (423), but were more 
effective on the response to histamine in cats (424). Diphenhydramine and 
tripelennamine blocked the induction of spastogenic action of serotonin, as well 
as the effects of histamine, in preparations of isolated guinea pig ileum (462). 
Erspamer (168) found that a rather impressive number of antihistaminic agents 
exert varying degrees of inhibition of the uterus-stimulating and antidiurectic 
effects of serotonin ("enteramine"). He states that pyribenzamine seemed to be 
the most active; benadryl, neohetramine, and phenergan, next in activity; antistin, 
the least active of the antihistaminics he tested. From these experiments he (168) 
concluded that the inhibiting action of these agents was in many respects inferior 
to that of certain sympatholytic drugs, such as dibenamine and dihydroergotamine, 
and that the effects of the antihistaminics on serotonin were not related to their 
effects on histamine, the autonomic nervous system, or directly on smooth muscle.
It has been suggested that the antagonistic action of dibenamine on the anti­
diuretic effects of serotonin and the inability of dibenamine to abolish or reverse 
the moderate and inconstant pressor effect of serotonin on anesthetized dogs 
result from competition between serotonin and dibenamine for an existing sub­
strate (170).
A nalogs and A ntim etabo lites
A number of antimetabolites which are structural analogs of serotonin, sym­
pathomimetic, and sympatholytic drugs (169) antagonize serotonin, and a sur­
prisingly large number of the antimetabolites inhibit or block adrenergic and/or 
antidiuretic action of this hormone (169, 632, 634) The characteristic effect of 
analogs is the result of their competing with serotonin for its normal receptor 
(632, 633), but they may have multiple effects in cells (452). 1-benzyl-l, 25- 
dimethylserotonin (BAS), a specific antimetabolite of serotonin, has the special 
advantage of blocking certain of the peripheral effects of this hormone and at the 
same time favoring the increase of serotonin in the brain in response to administra­
tion of 5-hydroxytryptophan in mice (638). Another water-soluble, rather active 
antimetabolite of serotonin, 2 ,5-dimethylserotonin, effectively antagonized the 
spastogenic action on isolated uterus and artery rings and the pressor action of
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serotonin in dogs (525). Woolley (632) holds that there are 3 principal classes of the 
naturally occurring antimetabolites of serotonin. The harmula alkaloids, repre­
sented by harmine; a second class represented by reserpine and yohimbine; and 
the ergot alkaloids, which include lysergic acid diethylamide (LSD) and ergot- 
amine.
Most of the known antimetabolites are active only on isolated preparations of 
organs or tissues and either are incapable of antagonizing serotonin in living 
animals or have a low potency (637). However, some of the methylserotonins, 
especially 2,5-dimethyl serotonin, are potent antiserotonins in vivo in dogs and 
on arteries and uteri in vitro (637).
R e se r p in e
Reserpine (Rau-sed, Serpasil), one of the 14 alkaloids obtained from Rauwolfia 
serpentina (426), apparently has two effects which inhibit the action of serotonin. 
It depletes by releasing the stored, and blocks storage (78, 333) of this hormone. 
Reserpine is thought to produce tranquility by blocking the binding sites of 
serotonin. Therefore it is concluded that free serotonin is necessary for the media­
tion of the sedative effect of reserpine (132). Reserpine releases serotonin stored 
in at least 17 sites in the brain of the dog (591), in the brain of other species, in 
the intestine, blood platelets, and elsewhere (248, 529, 530). Reserpine prevents 
storage of serotonin by incapacitation or blocking of the serotonin-binding sites 
in the brain and blood platelets (132, 248, 591) and causes blood platelets to lose 
their store of serotonin by disruption of the platelets (333, 530). It has been sug­
gested that reserpine lowers blood pressure and body temperature through its 
central action in relation to the concentration of serotonin, rather than of reserpine, 
in the brain (132). However, it should be noted that the mode of action of reser­
pine is not through hypnosis, for it stimulates activity of the activating system 
and "evokes the alert electrographic pattern" (477), and that phenidylate (ritalin) 
is strongly analeptic in cases of reserpine-induced depression (188).
Premedication with reserpine prevented the neurotropic effects of intra-arterially 
injected serotonin in dogs and prevented intracerebral edema following injection 
of serotonin into the cerebrum of mice (82). Intravenous injection of reserpine has 
a hypotensive effect. The work of Cronheim and Grouzis (122) shows that in 
urethane-anesthetized dogs, premedicated by intravenous administration of 
reserpine (1 mg/kg) 24 hours before infusion of serotonin creatinine sulfate (10.0 
mg/kg/min) at the rate of 0.5 ml/minute, resulted in a fall of about 62 (from about 
108) to 46 mm Hg in blood pressure and about 25 heart beats per minute. Bilateral 
vagotomy showed that integrity of the vagus nerves was not essential in this 
reaction. Since serotonin infusion had no observable effect on 5 normal dogs, these 
investigators hold that the supposed depressant effect of serotonin on the heart
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and blood pressure should be attributed to the direct effects of the reserpine which 
were made possible by the presence of the infused, free serotonin.
It has been suggested that the sedative and cardiovascular effects of reserpine 
are dependent upon the presence of free serotonin (122) and that the pharmacologic 
manifestation of reserpine on the brain may be either a consequence of, or merely 
concurrent with, changes in the brain serotonin content (77). Reserpine is one of 
the most potent releasers of serotonin; yohimbine, harmine, and certain other 
naturally occurring structural analogs of serotonin antagonize the action of this 
hormone on smooth muscle by competition (632).
L yser g ic  A cid D ieth yla m id e
Cerletti (94) shows that there is a formidable number of derivatives and com­
pounds of lysergic acid which show activities similar, although varying in degree, 
to lysergic acid diethylamide (LSD, LSD-25), other compounds which are com­
paratively inactive, and still others which are isomeric forms and, consequently, 
may occur in a variety of steric configurations. The result is that there is often 
confusion of terminology and of experimental and clinical results obtained. The 
designation most often encountered in the literature is "lysergic acid diethylamide 
(LSD)" or simply "lysergic acid" or LSD and, occasionally, LSD-25. Cerletti 
(94) employs "LSD" as a code, or abbreviation, for lysergic acid diethylamide in 
the title of his work.
The brom derivative of LSD (BOL, 2-brom-d-lysergic acid diethylamide) 
antagonized the stimulant effects of serotonin on smooth muscle in vitro very 
effectively and, in larger doses, suppressed serotonin-induced pressor-depressor 
responses in rats, but in general its systemic effects on dogs and cats were not so 
effective (500).
LSD, a hallucinagenic indole (587, 591) and naturally occurring analog of 
serotonin (632), has both serotonin-like and antiserotonin properties (632). LSD 
antagonizes the effects of serotonin in smooth muscle (632) and of administered 
serotonin on the central brain (77), and is used in neuropsychiatry to produce 
experimental mental states resembling schizophrenia (dementia praecox) (105, 
146).
It appears that lysergic acid diethylamide is specific in its inhibition of serotonin 
(189). Although Brodie, et al., 1955, state that the results of their work indicate 
that LSD blocks serotonin, Costa, 1956, reports that weak serotonin-produced 
uterine contractions are increased, rather than reduced or suppressed, by LSD, 
but that reserpine inhibited these contractions (260). LSD strongly antagonizes 
the vasoconstrictive effect of serotonin; as little as 1.0 fig of LSD inhibited the 
action of 2.0 to 10.0 fig of serotonin on vessels in the isolated perfused kidney of 
rats, but it increased the vasoconstrictive effect of epinephrine (94). This series
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of experiments shows that although LSD inhibits the vasoconstrictive action of 
serotonin it enhances this property in epinephrine.
Serotonin caused melanophores in the skin of a fish, Lebistes reticulatus, to 
contract and become spheroidal, but addition of LSD (25 /xg/ml) greatly expanded 
the melanophores and caused them to send out multiple processes (94).
The action of LSD apparently may be contingent upon multiple factors or 
conditions, for Marrazzi, 1957, states that LSD and serotonin, as well as several 
other drugs, produced inhibition of cerebral synapses in cats (77). LSD-25 has a 
high potency in producing symptoms simulating certain of the aspects of naturally 
occurring schizophrenia (367). It is also interesting in this connection that LSD 
produced reduction in cerebral cortical adenosine triphosphate, while chlorpro- 
mazine produced an increase in this energy-rich phosphate in the brain, especially 
in the hypothalamic tissue (260). Tolerance to LSD-25 may develop extraor­
dinarily rapidly, especially if heavy daily dosage (100.0 ng) is given to human 
patients. Thus, LSD-25 becomes "its own best antidote, or 'autodote' " (1).
The turnover of LSD is apparently very rapid, for Cerletti (94), by injecting 
mice intravenously with 35 mg/kg (total dose about 700.0 ^g) of LSD-25 and 
checking various tissues at 10-minute intervals for serotonin inhibition, determined 
that during the first two hours of the experiment the half life time of the LSD-25 
was 37 minutes. This is much more rapid than the turnover of labeled serotonin, 
which had a half life of 1 to 2 hours in the brain and 10 to 12 hours in the intestine 
(591). The foregoing experiments indicate that the production of LSD is at least 
twice as rapid as that of serotonin.
LSD is rapidly eliminated from the tissues and blood of an animal's body by 
being excreted chiefly in the bile, but small amounts (about 2%) may be eliminated 
in the urine or feces or by the lungs (94).
M iscella n eo u s  A gents
Among the various agents which antagonize the action of serotonin may be 
mentioned the following substances: Yohimbine particularly and many of the 
ergot alkaloids are antagonistic to serotonin (170, 423, 524) as an antimetabolite 
of serotonin (632). Certain structural analogs of serotonin are antagonistic (632, 
635). Monoamine oxidase, which in turn is inhibited by iproniazid, destroys 
serotonin rapidly (100). Amine oxidase rapidly inactivates serotonin (193), and 
probably many other substances also antagonize the action of this hormone. Also, 
Blaschko and Hellmann (61) found that pieces of tissues containing amine oxidase, 
including rat brain, guinea pig diaphragm, renal cortex (especially the proximal 
convoluted tubules) and liver, developed a precipitate which stained them dark 
brown when serotonin or tryptamine was added and the cultures incubated.
Local anesthetic drugs antagonize the stimulating effect of serotonin on isolated
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cardiac and smooth muscle, including the auricles of rabbits, ileum of rabbits and 
guinea pigs, tracheae of cats, and uterus of rats (535). Gaddum and co-workers, 
1954, found that in guinea pigs cocain effectively inhibited serotonin-produced 
contraction of the ileum but did not affect uterine contraction in rats (94).
Deficiency of pyridoxyal phosphate, a derivative of vitamin B e , may inhibit 
the formation of both serotonin and histamine since this substance plays an 
important part in all amino acid decarboxylations (591). Serotonin is formed by 
decarboxylation of 5-hydroxytryptophan by the enzyme 5-hydroxytryptophan 
decarboxylase (502, 334) and histamine is likewise formed from histidine by 
histidine decarboxylase (431, 504, 615). Chickens maintained from hatching to 6 
weeks of age on a diet low (about 1-2 % of optimum) in pyridoxine had an average 
of about 25.0 per cent of the normal amount of serotonin in the brain, intestine, 
blood, and liver (591).
D istribu tio n  of S erotonin
The significance of the distribution of serotonin in the body is more closely 
related to its potential production within tissues than to the actual occurrence of 
the hormone. Apparently, the presence in a structure of 5-hydroxy-L -tryptophan 
(192) or of the amino acid tryptophan (587), may be far more important than the 
presence of serotonin itself. There are at least 2 valid reasons for offering this 
suggestion. Free 5-hydroxytryptaminc is rapidly destroyed, apparently by metab­
olism catalyzed by monoamine oxidase (100, 591) and possibly by other agents 
(193, 591). Serotonin is made available at local sites chiefly by synthesis from the 
amino acid tryptophan, via 5-hydroxytryptophan (579, 588, 591). The 5-hydroxy­
tryptophan is converted into 5-hydroxytryptamine (serotonin) by action of a 
specific enzyme which is generally held to be 5-hydroxytryptophan decarboxylase 
(334, 587, 588, 591).
Serotonin, often in the form of a precursor (172), has been found widely distrib­
uted in nearly all of the structures, tissues, or cells in mammals and man, in at 
least certain structures in invertebrates (170, 171, 588), and in plants and bacteria 
(591). Variations in rate and quantity of serotonin production have been found in 
various structures and in the same structure at different times in the same inbred 
animals (591). For instance, it has been shown that in 17 regions of the brain of the 
dog the serotonin content varied from 0.17 to 2.1 /zg/g (591). Another group of 
investigators (9) report finding daily changes in serotonin content of the brain 
and slightly higher values in the brain of female than of male ZBC mice.
Serotonin was isolated and identified in beef blood plasma (461). Probably for 
this reason blood plasma was formerly believed to be the source of serotonin (339), 
but it is now known to be widely distributed (591), while blood platelets are 
considered the chief source of serum serotonin (457, 530, 646). Since serotonin is
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readily metabolized (100, 579, 591), its absence in a structure, tissue, or cell is 
insignificant, especially if its immediate precursor, 5-hydroxytryptophan, and the 
enzymes which synthesize serotonin from this substance are present. Most animal 
tissues contain "huge quantities" of an enzyme which "is highly specific for 
5-hydroxy-L-tryptophan" decarboxylating it to serotonin (591), but this decar­
boxylase has no action on the amino acid tryptophan (591).
R elation  of Sy n th esis  to D istributio n
The resistance of the blood-brain barrier to absorption of serotonin by the brain 
(77, 591), its ready permeability to orally administered 5-hydroxytryptophan 
(78, 587, 591), and the resulting increase in brain serotonin (78, 587) show con­
clusively that the distribution of serotonin may be strikingly related to the site 
of its synthesis.
Serotonin is formed in mast cells of rats (43, 334) and in certain structures in the 
body by the enzyme 5-hydroxytryptophan decarboxylase from 5-hydroxytrypto­
phan (207, 334, 587, 589, 591) and probably by all somatic cells by converting 
absorbed 5-hydroxytryptophan, or tryptophan via 5-hydroxytryptophan (587), to 
serotonin (77, 213, 587), especially following administration of 5-hydroxytrypto­
phan (77, 589). Activity of this serotonin-forming enzyme, 5-hydroxytryptophan 
decarboxylase, is strong in the gastrointestinal tract, kidneys, and liver (207, 
589), but it is feeble in bone marrow, blood platelets, and spleen; it is fairly strnog 
in certain areas of the brain and sympathetic ganglia in mammals (207). Sym­
pathetic ganglia in situ and homogenates of the excised ganglia of normal mammals 
have been shown to have a relatively high capacity for synthesizing serotonin, 
but all attempts to find free or preformed serotonin in these structures were 
unsuccessful (206). Certain other structures, notably the kidney of hogs, which is 
a commercial source of this enzyme, have been found to contain little or no sero­
tonin, but to be relatively rich in 5-hydroxytryptophan decarboxylase activity 
(588). 5-hydroxytryptophan decarboxylase "occurs exclusively in the nonparticu- 
late fraction of ultracentrifuged cells" (207). The distribution of the enzyme need 
not parallel that of extractable serotonin, but it may do so (207). The work of 
Walaszek and Abood (611) showed that most of the serotonin occurring in the 
brain of normal rats is bound to the mitochondria, but that the binding of serotonin 
to mitochondria is prevented by phenylether and to some extent by dinitrophenol.
When 5-hydroxytryptophan was administered to normal rabbits, serotonin 
not only increased in the structures where it usually occurs, such as the brain, 
blood platelets, and intestine, but also in structures where it is not usually found, 
such as the heart, kidneys, liver, and uterus (587). Similar effects were obtained 
by administration of this substrate labelled with C14 to rabbits, in which the 
serotonin in the depots of the body became so highly labelled as to suggest an 
increase in serotonin within the structures (587). Since it is held that administra­
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tion of 5-hydroxytryptophan is followed by formation of serotonin in all tissues 
of the body (77), it apparently would be logical to assume that those structures 
in which this hormone is not usually found, such as the heart, kidneys, liver, and 
uterus (587), metabolize serotonin rapidly, as suggested by Brodie, 1957 (632), 
and consequently would be expected to have a fairly high activity of 5-hydroxy­
tryptophan decarboxylase, as has been shown is true for the kidneys and liver 
(207, 589, 591). A more nearly direct approach is shown by the work of Udenfriend 
and Titus (589) in which serotonin was labelled by administering CI4-tryptophan. 
Their results show that the half life of the resulting C14-labelled serotonin was less 
than 2 days in the platelets and much less than 2 days in the stomach and intestine. 
Later work indicates that the half life of serotonin in the brain is only 1 to 2 hours; 
in the intestine it is about 10 to 12 hours (591).
R ecorded S it e s  of Occurren ce
In reviewing the literature on the distribution of serotonin one can hardly 
avoid often being in doubt of the validity of the investigator's claim to have differ­
entiated between the occurrence of serotonin and of histamine since similar tests 
are often employed to demonstrate the presence of both substances. The biological 
methods commonly employed for determining the presence or absence of serotonin 
in a tissue are usually unavoidably inadequate, while the quantitative procedures 
are, for the most part, so hampered by the shortcomings of the qualitative methods 
that the final results have little other than relative value. The first difficulty 
encountered is that, apparently as with histamine, injury to a tissue may result 
in a loss of serotonin comparable to the nature and extent the tissue is injured. 
Thus, it has been shown in iproniazid-treated rabbits that when brain or intestine, 
which are rich in monoamine oxidase activity, was tested it was found that the 
serotonin content was rapidly decreased following homogenization of the tissue 
(269). Curiously enough, it has also been found that if mice are pretreated with 
iproniazid, which has been shown to favor serotonin production by inhibiting 
monoamine oxidase activity in the metabolism of serotonin (591), no effect on 
the rate of serotonin metabolism by the whole animal could be detected. However, 
homogenized tissues from these mice failed to destroy serotonin, while the mono­
amine oxidase activity in slices of the tissues was not inhibited (591). Since it has 
been shown that in the brain, iproniazid inhibits activity of monoamine oxidase, 
which apparently catalizes the metabolism of serotonin, it is surprising that the 
monoamine oxidase in the homogenized brain or intestine was unable to destroy 
serotonin but was not inhibited in slices of the same tissues. A plausible explana­
tion of these results is that although in vivo effects of iproniazid in inhibiting 
activity of monoamine oxidase can readily be demonstrated, it is not as effective 
as might be indicated by data obtained by use of homogenates would imply (591).
Serotonin has a fairly wide occurrence in the structures of man and individuals
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of several species of mammals and lower forms. There is also the possibility that 
serotonin or its precursor forms may be found widely distributed in lower verte­
brates, invertebrates, and various forms of plant and animal life.
The gastrointestine, particularly the argentaffine cells (171), blood platelets 
(122), mast cells of rats (43, 334, 493), and certain areas of the brain (591) contain 
considerable quantities of serotonin. Serotonin also occurs in the lungs (591), 
in normal urine (585), occasionally in the spleen (423) and blood plasma, where 
its source is the platelets (457, 646), in sympathetic ganglia (206), in the posterior 
salivary glands of the common octopus, but not in Octopus macropus (172), in 
the skin of a toad, Discoglossus pictus (172), and in the venom of another toad, 
Bufo marinus (588). The presence of 5-hydroxyindole compounds has been re­
ported in plants and in bacteria (591).
The inability of investigators to find serotonin in a particular organism or 
tissue may be related to activity of antagonistic agents rather than to actual 
absence, as is suggested by the reported half life of labelled serotonin and one of 
its antagonists. The half life of lysergic acid diethylamide is about 37 minutes (94) 
and that of serotonin in the brain is about 1 to 2 hours, while the half life of 
serotonin in the intestine is at least 10 to 12 hours (591). This difference in half 
life of serotonin in two structures, each of which normally has a high serotonin 
content (94, 591, 632), is interpreted as indicating that serotonin is apparently 
formed more rapidly in the brain than in the intestine (591). Whether this rapid 
increase in production of serotonin in the brain is a response to the rapid destruc­
tion of this hormone or the rapid destruction is related to the rapid production 
apparently is an unanswered question.
Stomach and  I n testin e
The largest amount of serotonin found in any part of the body occurs in the 
gastrointestine, but its function is not understood (591). Neither, apparently, is 
its source in the gastrointestine definitely known. Erspamer, 1953, found that the 
serotonin content varied greatly in different regions of the intestine in different 
individuals of a single species as well as in different species of mammals and other 
vertebrates (423). Some investigators (171, 172) apparently believed that from a 
physiological, if not quantitative, point of view the argentaffine cells, or the 
mucosa (269), in the stomach and intestine are the most important source of 
gastrointestinal serotonin. The argentaffine cells of the stomach and intestine 
occur singly and are scattered between the zymogenic cells and the basement 
membrane and rarely occur in the villi but are scattered singly between the cells 
lining the crypts of Lieberkiihn. Argentaffine cells are never abundant in the small 
intestine, but are most numerous in the vermiform appendix in man (374). For 
these reasons it seems strange indeed that these argentaffine cells should supply
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enough serotonin to warrant the conclusion that the gastrointestine is the richest 
source of this hormone in the body (591). Likewise, there appears to be no explana­
tion for serotonin in the intestine being more resistant to release by reserpine than 
that in the blood platelets or brain of rabbits (248).
The human appendix has the densest population of argentaffine cells found in 
the gastrointestine and these cells average 5 to 10 in each crypt of Lieberkiihn 
(374). Since carcinoids arise from argentaffine (Kultschitzky, enterochromaffine) 
cells (626) it is not surprising that some of these characteristically yellowish tumors 
should have an unusually high serotonin content, particularly among those arising 
in the veriform appendix. Langemann and Kagi (336), Udenfriend, 1957 (591), and 
others call attention to the fact that patients with malignant carcinoid have hyper- 
serotonemia. However, Udenfriend also points out that not all patients with 
carcinoid have hyperserotonemia, for these individuals may have a blood sero­
tonin level ranging from small to excessive amounts (591). A carcinoid found in 
the appendix of a woman had the extremely high serotonin content of 952 yug/g 
of fresh tissue; while normal appendiceal tissue had a value of only 1.0 /ug/g- 
It was estimated that the capacity of this carcinoid for forming serotonin was 
about 35 times that of the normal human appendix (208).
C en tra l  N ervous System
Although much attention has been paid to the serotonin content of the brain 
(94, 632), the total amount of serotonin in the brain is believed to be only "a 
fraction of a per cent" of that in the body (591). Nevertheless, because of its 
neuropharmacological implications, probably more work has been done on rela­
tions of serotonin to the brain than to the remainder of the entire body.
It has been shown, by employing a method of testing based on fluorescence, 
that the serotonin content of different areas in the brain of the dog varies con­
siderably. Of the 22 morphophysiological areas tested in these dogs, no serotonin 
could be detected in 5; the serotonin content in the 17 other areas varied from 0.09 
Mg/g (cerebellum) to 2.1 M g/g (amygdala) (591). These results indicate the high 
degree of inaccuracy which may be expected in assays of samples of brain taken 
at random or from unidentified areas of the brain of various animals or man.
Administration of the amine oxidase inhibitor, iproniazid (50 m g/k), to rats or 
rabbits produces a large increase of serotonin in the brain in a short time, since 
metabolism of the serotonin is inhibited as a result of the inactivation of mono­
amine oxidase. However, it was found in determining the serotonin values in the 
brain of these animals that in intact slices of the tissues, monoamine oxidase was 
not inhibited, but that, this enzyme was totally inhibited in the same tissue after 
it had been homogenized (591).
It was found by differential centrifugation that 60 to 75 per cent of all the
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serotonin occurring in the brain of the rat is bound to mitochondria and that the 
remaining 25 to 40 per cent is scattered among the supernatant fractions and nu­
clear debris (611). However, other investigators report that differential centrifuga- 
tion of homogenate of rabbit brain failed to show that serotonin has a particular 
affinity for any of the cell fractions (269).
Both of these observations may be correct for the particular species being used, 
or unrecognized technical or other factors may have played a significant part in 
the results obtained. For instance, it has been found that the serotonin content 
of tissues in general (269), specifically of rabbit brain (269), rapidly diminishes 
after homogenization. Also, it has been found that phenylethyl prevents binding 
of serotonin to intact mitochondria (611), that monoamine oxidase rapidly meta­
bolizes this hormone (591), and that there are other agents which rapidly deplete 
tissue serotonin (269, 591, 611, 632). A point to be remembered is that probably 
none of the serotonin-blocking agents is specific for serotonin (483).
B lood P la t elet s
It has been pointed out that little is known about either the amount or distri­
bution of serotonin in the blood (591), but Rand and Reid (457) and Zucker and 
Rapport (646) hold that the blood platelet is the source of plasma serotonin. They 
estimated the amount of serotonin in platelets as being 1 X  10~9 /jg/platelet for 
man and 1.7 X  10~9 /zg/platelet for cattle. Rand and Reid (646) found, by differ­
ential centrifugation of citrated beef blood, that an extract from plasma con­
taining platelets was active on isolated rat uterus or guinea pig intestine, but that 
when the platelets were removed before extraction of the plasma the extract was 
practically inactive whether or not it contained erythrocytes.
Other investigators (52, 423) have shown that removal of the platelets from nor­
mal blood serum clearly reduced its vasoconstrictor potency. The presence of 
heparin in platelet-rich plasma inhibited its vasoconstrictor activity, but after 
fragmenting the platelets by freezing to — 70 C and thawing 3 times, the vaso­
constrictor activity of the heparinized platelet-rich plasma was greatly enhanced 
(52). Thrombocytopenia is commonly accompanied by reduced plasma serotonin 
activity (52, 423). In a group of 9 thrombocytopenic subjects having a platelet 
count less than 100,000/ml all had diminished plasma serotonin activity (52); 3 
thrombocythemic patients with 2-4 million platelets/ml also had decreased sero­
tonin activity (52). These 3 patients had multiple complications which might 
account for the reduction in serotonin activity. The results of these experiments 
and observations convinced the investigators that the platelet is the source of 
serum serotonin but did not eliminate the possibility of other factors being in­
volved (52). This adds interest to the suggestion that the principle found in plate­
lets and blood serum causes increased blood pressure in cats by provoking a dis­
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charge of epinephrine (520), for it is held that usually serotonin is primarily a 
depressor in cats (422).
Blood platelets from rabbits and mice apparently contain appreciable quanti­
ties of both serotonin (122, 248, 529, 530) and histamine (60, 595). However, as 
stated by Dale, 1956, blood platelets of the horse contain no histamine at all (60).
There appears to be some difference in opinions concerning the question of how 
serotonin gets into the blood platelets. Two investigators (645) found that human 
and canine platelets in 0.2 to 4.0 n g / m \  concentration of synthetic serotonin for 
5 or 10 minutes at room temperature absorbed some of the serotonin. Experiments 
in which platelet-rich canine or human plasma or platelets in whole blood were 
used produced variable, mostly negative, results due to disappearance of the 
serotonin in the cultures. They (645) found that washing the platelets prevented 
disappearance of the serotonin in vitro in 4 of 9 experiments using canine platelets 
and in all 5 using washed human platelets. These investigators (645) also hold that 
most, if not all, of the serotonin in human platelet-rich plasma could be recovered 
from the platelets. They apparently correlated the ability, or inability, of platelets 
to absorb serotonin with morphological appearance rather than with the possible 
presence or absence of enzymes, such as monoamine oxidase, which is credited 
with the ability to catalyze the metabolism of free serotonin rapidly (423, 591).
Administration of C14-labelled tryptophan, which was incorporated into the 
serotonin, indicated that 5-hydroxytryptamine is stored in the platelet during 
its formation and that the serotonin remains in an inactive state within the plate­
let until it disintegrates and releases the hormone into the plasma where it is 
rapidly inactivated (100, 590). It is reported that the amount and rate of serotonin 
released from blood platelets is related to the extent and rate of disintegration of 
the platelets (230). However, other investigators observed complete release of 
platelet serotonin without detectable alteration in the form or structure of the 
corpuscles (595) and without causing the platelets to cohere, agglutinate, or disin­
tegrate (644) or show any injury (52). Also, washing blood platelets with an iso­
tonic salt solution does not free the contained serotonin (78). However, it is held 
that the blood platelet does not form serotonin from 5-hydroxytryptophan, but 
that the serotonin is synthesized at the site and stored during formation of the 
platelet (590). Thus, by inference, it appears that the actual synthesis of platelet 
serotonin normally takes place in precursor cells of the platelets in bone marrow, 
which would probably be the megakaryocytes. This is very interesting since rabbit 
platelets, which contain appreciable amounts of both serotonin and histamine, 
decarboxylate C14-histamine in stable condition (506). Thus, in latitude of distribu­
tion, serotonin shows a strong tendency to parallel histamine.
The serotonin of blood platelets apparently is more sensitive to chronic adminis­
tration of reserpine than the brain and much more sensitive than the intestine in
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rabbits (248). A single large dose of reserpine (5.0 mg/k) caused release of nearly 
all of the serotonin in blood platelets, brain, and intestine in laboratory animals; 
chronic daily administration of light doses (1.0 mg/k) over a period of 10 days 
freed about 95 per cent of the platelet serotonin in 3 hypertensive patients (248). 
Daily administration of reserpine (0.015 mg/k) caused progressive reduction of 
platelet serotonin in rabbits (248).
i 'harmacophysiologic Activity
Pharmacologically, or in vitro, serotonin has a generally spastogenic effect on 
smooth muscle (77, 94, 193, 424, 462, 483, 520, 528, 535, 591, 633). The spasto­
genic effect on excised smooth muscle is further discussed under tests for serotonin 
and under serotonin compared with histamine.
The primary physiological, or in vivo, effect of serotonin, either endogenous 
or exogenous, is that of a pressor agent (171, 172, 213, 422, 461, 466, 520, 635). 
It appears, in general, that the pressor action of serotonin is directly the result of 
its spastogenic effect on the muscular wall of arteries, for this pressor effect was 
abolished by feeding dogs an antiserotonin, 2-methyl-3-ethyl-5-nitroindole (a 
structural analog of serotonin), before intravenously injecting the serotonin (635). 
However, there is the possibility that neural intervention may be involved, at 
least in certain instances. This idea of neural intervention is supported by the 
finding that intravascular injection of serotonin caused nonmedullated afferent 
vagal nerve fibers to discharge, apparently by stimulating the thoracic and/or 
abdominal origins of these fibers (141). Serotonin is reported as being a very 
strong synaptic inhibitor, is 25 to 30 times as potent as adrenalin, and may eventu­
ally be shown to be the chief neurohumoral inhibitor of synaptic transmission 
(367). So important is serotonin in mental activity that it has been suggested 
that upset in the regulation of this amine may be responsible for illness arising 
in the brain (367).
Va r ia b l e  and V arious E ffects
Administration of serotonin is often followed by various, sometimes unexpected, 
results on structures containing smooth muscle. In general this may be partly 
explained by the fact that the dosage of serotonin alters the neurotropic effect of 
this hormone so that instead of a simple incremental change a biphasic effect is 
produced. For example, injection of low dosage of serotonin into the internal 
carotid artery causes spastic paralysis of a transient nature, while high dosage 
produces flaccid paralysis without causing the usual cerebral edema, and both 
types of paralysis are inhibited by reserpine (82). This neural relation is somewhat 
furthered by Page (423) who favors the tenet that serotonin plays a part in nerve 
metabolism, and he suggests that this hormone may have an important role in
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the mechanism of traumatic and hemorrhagic shock and in myocardial infarction. 
Welsh, 1948, considering the effect of serotonin on the heart of Venus mercenaria 
in being able practically to duplicate the effects produced by stimulating the 
regulatory nerves, suggests that one of the normal functions of this hormone may 
be to regulate the excitatory nerves of this marine clam's heart (423).
Page and McCubbin (424) point out that the response of arterial pressure in 
man and animals to serotonin results from several variables within the individual 
and that various species may respond differently. Hypertensive people and dogs 
have similar responses to serotonin, but their responses differ from those of rabbits 
and cats. In dogs serotonin is primarily a pressor, but in cats it is primarily a 
depressant (422). Another point is made by various investigators (426) who hold 
that whether serotonin dilates or constricts peripheral blood vessels depends to a 
great extend upon dosage: minute doses produce vasodilation; larger doses pro­
duce vasoconstriction.
Serotonin affects a rather wide range of physiological and other processes. 
Pretreatment with this hormone significantly increased the incidence of survival 
in rats subjected to lethal dosage of X  rays (228). There is evidence that serotonin 
plays a part in regulating the excretion of water and electrolytes, particularly 
since it has been shown that increased serotonin decreased excretion of sodium in 
dogs (57). Serotonin has been shown to inhibit the uptake of endogenous oxygen 
in vitro by brain homogenates from iproniazid-treated mice (100), to play an 
important part in regulating blood pressure and temperature (132) and to mediate 
the actions of reserpine (77, 132, 591, 632). This hormone also increases epinephrine 
in cats (466).
Serotonin creatinine sulfate (SCS, 10-20 /xg) invariably produced a fall in both 
cortical oxygen tension and in systemic blood pressure in cats, although it is also 
stated that this hormone is a potent stimulant of smooth muscle in peripheral 
blood vessels; 5.0 to 10.0 ng of SCS depressed electrically evoked potentials from 
the cerebral cortex (139). Intravenous injection of SCS produced immediate 
hemostasis in peripheral wounds in experimental animals and had similar effects 
on a group of eviscerated and on several heparinized rats. This hemostasis was of 
short duration but could be prolonged by reinjection of SCS. Instead of SCS 
being antagonistic to histamine, the toxicity of the two drugs was found to be 
additive (114).
V asomotor R fxations
The earlier work with serotonin, as well as most of that which has been recorded 
to date, indicates that the primary relation of serotonin to the blood vascular 
system is that of a pressor agent. However, some investigators hold that under 
certain conditions serotonin causes reduction in blood pressure. Thus, it is very
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difficult to evaluate the vasomotor effects of serotonin, for both pressor and 
depressant effects are recognized in the seemingly controversial literature. The 
entire situation when summed up generally indicates that a preponderance of 
investigators and writers consider serotonin as being primarily a pressor agent, 
but they may also concede a certain extent of depressive action. At least 2 investi­
gators point out that the physiological intervention and significance of serotonin 
in local vasoconstriction in other than intrarenal vessels have not been proved 
satisfactorily (171). Other investigators suggest that serotonin is, under certain 
conditions at least, an edema-producing agent (493). Another investigator was 
unable to find any direct correlation between "increased capillary fragility" 
and low level of serum serotonin, although he observed that these two condi­
tions were often associated in man (52).
P resso r  E ffects
Most of the numerous papers, notes, and abstracts leave the reviewers no occa­
sion to doubt that the investigator in each instance holds that the substance he 
was using, which he believed was serotonin, is a vasoconstrictor, or pressor, 
agent. Others, however, intimate that dosage determines whether serotonin is a 
vasoconstrictor or a vasodilator. Certain investigators hold that serotonin causes 
increased capillary permeability; others hold that this hormone, when freed by 
histamine-releasing substances, including dextran, compound 48/80, and ovomu­
cin, which damage mast cells, is the agent which produced edema in rats (493). 
However, it is stated that this edema is mediated by the combination of serotonin 
and histamine or of closely related substances (493).
Serotonin powerfully constricted coronary and carotid arteries in swine (542), 
had an initially variable effect on the systemic arteries, but always reduced the 
mean systemic arterial pressure after about 3 minutes of continuous infusion 
(20-150 /xg/kg/min) in dogs. In 11 experiments under these conditions, the mean 
pulmonary pressure increased 300 per cent, but the mean systemic arterial pressure 
decreased 28 per cent, while the cardiac output rose 60 per cent in the dogs (494). 
The pressor action of 5-hydroxytryptamine, when assayed in dogs, is 3 times as 
potent as 7-hydroxytryptamine (422). It was found that serotonin (2.0-8.0 n g / k g ,  
intravenously) is at least 10 times as potent in stimulating respiration in dogs as 
tryptamine (142) and that it is a pressor of both systemic and pulmonary arterioles 
(466) in dogs.
H ypo ten siv e  E ffects
Although serotonin is preeminently a pressor agent it may cause variously 
reduced blood pressure. Intravenous injection of 10 to 200 p.g of serotonin caused 
successively initial fall and a rise followed by a more prolonged fall in systemic
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arterial pressure in chloralosed cats. This effect was not altered by atropine, spinal 
section, or vagotomy (465). Silva (531) reports only hypotensive effects of intra­
venous injection of serotonin in toads.
Intravenous injection of 50 to 100 /ng/kg of serotonin always caused an abrupt 
fall in blood pressure, respiratory arrest, and other symptoms in cats. Ganglionic 
block reversed the blood pressure response but prolonged the period of respiratory 
arrest. Further work on these cats indicated that in this animal serotonin produced 
a von Bezold-Jarisch reflex by affecting the peripheral autonomic sensory endings 
(508). Other investigators obtained similar results in chloralosed cats by rapid 
venous injection of 5-hydroxytryptamine creatinine sulfate, but in addition to the 
profound reflex cardiopulmonary change, which included the Bezold-Jarish reflex, 
pulmonary vasoconstriction, as indicated by increased right ventricular pressure 
and bronchoconstriction, was noted (111). It has also been found that small 
amounts (2.0-10.0 jug) of serotonin injected into the region of the carotid sinus 
produced a fall in blood pressure and an increase in respiration, which was usually 
preceded by apnea of short duration, in cats. Section of the nerve to the sinus 
abolished both the vascular and respiratory responses, but apnea remained. 
Similar injections into the regions of the aortic bodies had parallel effects on the 
vascular and respiratory systems which, likewise, were abolished by vagotomy. 
These responses to the local administration of serotonin are explained by the 
investigators in terms of the respiratory stimulation being due to chemoreceptors 
and the fall in blood pressure to the baroreceptors (211).
A n tid iu retic  A ctivity
It is generally conceded that serotonin inhibits diuresis in man, rats, and various 
other mammals (173, 175); however, investigators are not in accord as to its mode 
of action. Two main approaches to an explanation of the mode of action of sero­
tonin in effecting antidiuresis are in vogue. Briefly, in one approach the vasocon­
strictor effect of serotonin on the afferent glomerular arterioles is stressed; in the 
other its effect on the water reabsorption mechanism of the renal tubules is stressed. 
The available information suggests the probability that both approaches play a 
part with afferent arteriolar constriction playing the major role. The extremely 
high reabsorption values for glomerular filtrate as it passes through the renal 
tubules reported by various investigators for normal man and animals indicate 
the difficulty, if not impracticability, of determining the effect of administered 
serotonin on tubular reabsorption in normal animals and man. For instance, it has 
been estimated that normally 90 per cent of the water in glomerular filtrate is 
reabsorbed by the renal tubules in the frog (41) and that this value reaches 99 
per cent in man (160).
A normal human adult produces about 180 liters of glomerular filtrate per day,
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of which only about 1.5 liters ("about 1.0%") per day is excreted from the body 
as urine (160). The small amount of glomerular water (about 1.0%) normally 
excreted in man (160) suggests that the potent antidiuretic effect of neurohypo­
physial extract, which is generally believed to act directly upon the renal tubules 
to increase their reabsorption of glomerular filtrate (41), actually effects antidiure- 
sis chiefly by constricting the efferent glomerular arterioles (41).
Erspamer and Ottolenghi (174) were so impressed with the antidiuretic action 
of serotonin, extracted with acetone from the posterior salivary glands of Octopus 
vulgaris, on the rat that, as a working hypothesis, they adopted the tenet that 
serotonin regulates the function of the kidney. Certain other investigators (55, 
57, 127, 499) are not convinced that serotonin plays an especially significant part 
in regulation of the renal output by controlling the glomerular arterioles. Sala 
and Castegnaro (499) report that small doses (0.1-0.3 mg/kg) of serotonin injected 
either subcutaneously or intravenously acted as an antidiuretic without stimulat­
ing smooth muscle in hydrated dogs. Chiefly from this effect, they concluded that 
serotonin reduced the flow of urine by increasing reabsorption of water as the 
urine passed down the renal tubules. If this were the case, the specific gravity of 
the urine of the serotonin-treated dogs should be altered. Dasgupta (127) found 
that pretreatment with chlorpromazine (a vasodilator) protected hydrated rats 
from the antidiuretic action of serotonin. From this work he concluded that the 
antagonistic effect of chlorpromazine on serotonin-induced antidiuresis may be 
explained in terms of its effect as a vasodilator or, possibly, by its effects on the 
water reabsorption mechanism of the renal tubules.
A point of interest is that in all the works reviewed on the antidiuretic effects 
of serotonin, we found no indication that the investigator had considered the 
possibility that insufficient intake or utilization of protein may have been a 
contributing factor. It has been shown that a protein-deficient diet causes a pro­
gressive increase in antidiuretic activity in rats (55).
S erotonin C ompared  with H istam in e
The discovery that serotonin occurs within and is synthesized by mast cells 
(43, 334, 493), that mast cells also contain histamine (42, 402, 474, 475, 476, 617) 
and that serotonin is not formed from 5-hydroxytryptophan by platelets, but is 
probably transferred to the platelet during its formative period (590) whence it 
may be released (457, 475) along with histamine (43, 60, 609), further complicates 
the problem of differentiating serotonin and its activities from histamine and its 
activities. Species differences in response of a structure to serotonin may be taken 
as an indication that results of biological assay of the structure in question may 
have only relative value. For instance, it has been shown that strips of the carotid 
artery of cattle are very sensitive to serotonin, but similar strips of this artery 
from swine and dogs are so nearly insensitive t o this hormone as to render the por­
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cine and canine material undesirable for biological tests (423). Small amounts of 
serotonin or of histamine increased the coronary flow when injected into the 
coronary artery of the dog, while an extract of the neural hypophysis reduced it 
(510).
So far, it appears that the two amines are much more reliably differentiated 
chemically and physically than by their pharmacological activities, which appear 
to differ chiefly in potency if smooth muscle is used for the assay (189). Although 
serotonin (5-hydroxytryptamine) and histamine (5-imidazoleethyl-amine) (389) 
are both amines and are both produced in nat ure by decarboxylation (77, 200, 504, 
505, 591), they are recognized as different chemical entities and are usually ac­
corded opposite pharmacological effects, the possibility of mistaking the effects 
of one for the effects of the other exists.
T ests  for S erotonin
Certain investigators have employed the method of a) fluorescence (77, 530, 
591), b) a specific chemical method (590), c) electrophoresis (585, 588, 646), 
d) blood pressure (508, 632), e) motor activity of the bladder (165, 171, 193), 
f) gastric juice production and/or bronchiolar tone (165, 193, 284, 508), g) nictitat­
ing membrane of the cat (466), h) kidney of the cat (94, 466), i) perfused isolated 
rabbit ear preparations (94, 422, 461) and other procedures. However, the most 
commonly used method is a form of biological assay of extracts employing smooth 
muscle, such as rabbit's ileum (461), but usually the guinea pig's ileum (165, 
198, 207, 284, 462, 591, 632), colon strips of the rat (43), uterus of rat or guinea 
pig (94, 171, 457, 483, 632, 637), or a muscular artery (52, 94, 169, 457, 466, 632, 
634, 63 7). The isolated heart of a marine clam, Venus mercenaria, is recommended 
as being very sensitive to serotonin (585) and has been successfully used by others 
(423 , 491, 613); the trachea of cats and the auricles of rabbits have also been 
used (535).
The biological methods employed by some investigators for the identification 
of serotonin apparently fail to differentiate sharply the action of serotonin from 
that of histamine, since some of these methods, especially those employing uterus 
or intestine, commonly have been used to detect the presence of histamine (47, 
341, 547). Even though serotonin regularly has pronounced spasmogenic action 
on certain prepared, isolated smooth muscle structures, such as segments of carotid 
artery (52, 636), uterus of guinea pigs, mice, or rats (189, 201, 466, 636), intestine 
of guinea pigs (466, 528), the colon of rats (43), and heart of Venus mercenaria 
(206, 585), this reaction of smooth and cardiac muscle is far from being specific 
for serotonin. For example, acetyl choline 1:5 million, histamine 1:5 million, or 
barium chloride 1:500,000 in Locke-Ringer solution is each spasmogenic for iso­
lated guinea pig uterus or ileum (528).
The uterus of mice sensitized with egg albumin contracts in vitro when eggwhite
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is added (189). However, it is held that isolated strips of normal or sensitized 
uterus is 1,000 times more sensitive to serotonin than it is to histamine (189, 311). 
In this connection it is interesting to note that injection of mice with H. pertussis 
cells produced increased sensitivity to both serotonin and histamine (311, 404, 
405).
Erspamer's, 1953, method of using the atropinized uterus of spayed rats after 
administration of strongly physiologic doses of estrogenic hormones affords test 
material which is very sensitive to serotonin (in dilutions up to 1:200 million) 
and is negligibly sensitive to histamine (423), and appears to offer a reliable means 
for differentiating the spasmogenic action of serotonin from that of histamine. 
However, as has been pointed out for other techniques (591), the possibility exists 
that the effects of related substances, such a certain analogs, may be indistinguish­
able from the effects of serotonin.
Another interesting point pertaining to the specificity of the effects of serotonin 
is that although apparently not all antihistamines are capable of blocking the 
spastogenic effects of serotonin on smooth muscle, diphenhydramine and tripelen- 
namine do prevent the induction of spasm in preparations of isolated guinea pig 
ileum by acetyl choline and histamine as well as by serotonin (462). However, 
attention should be directed to the finding that administration of antihistaminic 
drugs failed to inhibit anaphylaxis of isolated uteri strips, or in the intact mouse 
(189).
Several factors probably affect the results obtained by using smooth muscle, 
but the physiological state of the tissue being used is probably the one most often 
overlooked. Erspamer (170) states that the uterus of rats in estrus apparently is 
the best test object for the presence or assay of serotonin; others (632) advocate 
pretreatment of rats with estrogens to insure uterine response. Various investiga­
tors (483) have shown that the sensitivity of the uterus of the rat to serotonin is 
high during estrus and in pregnancy, but diminishes during diestrus, immediately 
following partuition, and after ovariectomy; Woolley (632) states that "the uterus 
will not respond to serotonin except during estrus". These objections are ap­
parently overcome by Twarog and Page (585) who recommend use of the isolated 
heart of Venus mercenaria, a marine clam, as providing a selective and highly 
sensitive means of assaying serotonin activity.
Immersion of a section of guinea pig ileum in a strong solution of tryptamine, 
5-hydroxytryptamine, or substance P causes contraction in the piece of intestine, 
but this contraction ceases in a few minutes in spite of the continued presence of a 
potent amount of the excitor in the solution. After the piece of intestine has been 
desensitized by the excess of either tryptamine or 5-hydroxytryptamine it is in­
sensitive to both substances, but remains sensitive to other stimulating substances 
(198). This reaction is interpreted as indicating that the stimulating effect of tryp-
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tamine and of 5-hydroxytryptamine is mediated by one type of receptor in the 
intestine and that some other substance, such as histamine, causes contraction of 
the ileum by stimulating other receptors. Nevertheless, there apparently is no 
adequate method of bioassay by which intestinal contraction caused by serotonin 
can be differentiated from that caused by histamine or certain other agents.
M etabolism  of S erotonin
Sjoerdsma and co-workers, 1955, found that the enzyme monoamine oxidase 
apparently catalyzes the metabolism of serotonin (591). Other work shows that 
serotonin is rapidly metabolized by monoamine oxidase when the hormone is 
liberated in reasonable amounts (77) or administered parenterally (589, 590, 591). 
That histamine is similarly destroyed by the enzyme histaminase is generally con­
ceded, with few exceptions (16), but whether or to what extent diamine oxidase 
and various other factors are involved is still controversial (295, 504, 569, 641). 
Schayer (504) recognizes 3 kinds of mammalian enzymes which metabolize hista­
mine in physiological amounts. These are an acetylating enzyme, diamine oxidase, 
and 'histamine-metabolizing enzyme I I ', which is probably a composite of an 
oxidative and a methylating enzyme (504). These enzymes have varying degrees 
of efficiency in different animals (504).
U r in a r y  S erotonin and H istam in e
Since free serotonin, exogenous as well as endogenous, is rapidly metabolized 
(100, 589, 591) by far the major part recovered in the urine is in a degradated, 
inactive state, usually in the form of 5-hydroxyindoleacetic acid (589, 590, 591), 
primarily as a result of metabolism of the serotonin by oxidative deamination 
(589, 590, 591).
The kidneys and liver appear to contain significant quantities of an enzyme 
which is similar to, if not identical with, monoamine oxidase and catalyzes the 
metabolism of serotonin (591). When serotonin was aerobically incubated with 
homogenates of either kidney or liver, about 30 per cent of the metabolized hor­
mone was recovered as 5-hydroyindoleacetic acid; the other 70 per cent was uni­
dentifiable as any known compound (589). Similar results were obtained in vivo 
in which 20 to 30 per cent of the serotonin administered to dogs was recovered from 
the urine as 5-hydroxyindoleacetic acid in addition to several indoles which were 
not identified (589).
Since both serotonin and histamine are excreted chiefly by the kidneys, the urine 
content bears a fairly definite relation to the intake of these amines. This relation 
is much more significant for histamine than for serotonin since both free and par­
enterally administered serotonin are rapidly inactivated through oxidative deami­
nation by monoamine oxidase, while very little of the parenterally administered
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histamine is degradated. The result is that the amount of free urinary histamine 
bears a relation to the amount of free histamine administered (200). Likewise, the 
amount of conjugated histamine in the urine is related to the amount that was 
metabolized (200). However, a considerable error may be introduced into this 
evaluation by certain hypertensive renal-vascular conditions, especially with re­
gard to the relation of the amount of serotonin metabolite to the intake. It has 
been observed that chronic glomerular nephritis or advanced renal disease of 
malignant hypertension reduced the amount of urinary 5-hydroxyindoleacetic 
acid in man (68).
Another probable source of error lies in the fact that there is a considerable 
amount of evidence indicating that synthesis of both serotonin and histamine is 
inhibited by deficiency of pyridoxine (pyridoxine phosphate, vitamin Br,). This 
effect is not specific for either substance, for pyridoxine appears to play an impor­
tant part in decarboxylation of amino acids in general and for metabolism of 
epinephrine and norepinephrine (591) as well as for decarboxylation of 5-hydroxy­
tryptophan and histidine.
Acetone extracts of urine from normal dogs and people contained 0.1 to 1.0 
Mg/ml of serotonin (which is comparable to the 0.1 to 0.4 jug/ml serum content of 
heparinized dogs), and venous infusion of serotonin increased the urine content 
of this substance (585). However, the normal, daily output is astonishing, for it 
has been estimated that normal dogs excrete about 2.0 to 3.0 mg, and human sub­
jects about 7.0 to 10 mg, of 5-hydroxyindoleacetic acid per day (579, 589). These 
amounts presumably account for most of the dietary values, for daily output 
indicates that the turnover of serotonin in tissues is probably much larger than 
has been suspected (579).
The urine of dogs treated with serotonin yielded 20 to 30 per cent of the admin­
istered dose of serotonin in the form of 5-hydroxyindoleacetic acid, while the urine 
of those receiving 5-hydroxyindoleacetic acid yielded unchanged nearly the entire 
amount that was administered (589). From these values the authors calculated 
that in human subjects about 20 mg of serotonin was metabolized daily to produce 
7 mg of 5-hydroxyindoleacetic acid daily (589).
The urine of large carnivores, including lions and tigers, had an unusually high 
concentration of conjugated histamine (200) which had a dietary origin, for par- 
enterally administered histamine produces an increase in free histamine but has 
little effect on the level of conjugated histamine in the urine (200).
R en a l R  elation s
The part played by the kidneys in the synthesis and/or metabolism of serotonin 
and histamine in different mammals is obscure. Apparently, the kidney of most 
mammals contains very little or no serotonin, but it has been shown that serotonin
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appeared in the kidneys of normal rabbits, where it is not normally found (587, 
591), after administration of 5-hydroxytryptophan (587). The results of these 
experiments appear to indicate that in the kidneys of the rabbit serotonin is me­
tabolized about as rapidly as it is formed. Walton, 1956, found that the kidney of 
the house cat contains an appreciable amount of histaminase but no, at least no 
detectable, histidine decarboxylase, while the kidney of normal rabbits contains 
very little or no histaminase, but has a fairly strong histidine decarboxylase ac­
tivity (200) and contains no measurable amount of serotonin (587). These findings 
indicate that the kidney of rabbits contains no histamine and no serotonin, but 
that it has the enzyme necessary for synthesizing histamine, while the kidney of 
hogs is well equipped to synthesize serotonin and inactivate histamine, for it con­
tains appreciable quantities of 5-hydroxytryptophan decarboxylase (588) and is 
one of the best sources of histaminase (381, 591). The kidney of hogs not only con­
tains the enzyme necessary for synthesizing serotonin (588), but contains it in 
sufficient quantity to be a commercial source of 5-hydroxytryptophan decarboxyl­
ase, and McHenry and Gavin (381) described a method for obtaining a stable 
powder high in histaminase activity from this source. The results should be inter­
esting if the data on the occurrence of the above substances in a wide range of 
mammalian kidneys were tabulated. However, Brodie's statement to the effect 
that serotonin is formed in all tissues of the body following administration of 5- 
hydroxytryptophan (77) indicates the ability of all body tissues, as well as the 
kidney, to form serotonin.
There is evidence that other metabolic products of serotonin occur in the urine, 
some of which apparently have pharmacologic properties of serotonin. Ketty calls 
attention to the work of Bumpus and Page, 1955, in which they isolated substances 
from normal human urine which they considered methylated derivatives of sero­
tonin (419). In addition to traces of bufotenin (dimethyl serotonin) occurring in 
the human urine, methylation of serotonin has also been reported in plants, in 
certain invertebrates, and in a toad (591).
It is generally conceded that following administration of histamine-releasing 
agents (341) or administration of histamine (504), there is an increase in urinary 
histamine (200); and it has been shown that this urinary histamine is spastogenic 
for atropinized guinea pig ileum (341). Also, the works of Mclntire, et al., 1947, 
Rosenthal and Tabor, 1948, and Millican, et al., 1949, show that after separation 
by Mclntire and co-workers', 1947, method for other urinary substances, hista­
mine is the only remaining spastogenic substance acting on atropinized ileum of 
the guinea pig (341).
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